Combination of Cryosurgey and NK Immunotherapy for Recurrent Laryngeal Cancer
The aim of this study is the safety and efficacy of cryosurgery plus NK immunotherapy to recurrent laryngeal cancer.
Recurrent Laryngeal Cancer
DEVICE: Cryosurgery|BIOLOGICAL: NK immunotherapy
Relief degree of tumors, It will be evaluated by the Response Evaluation Criteria in Solid Tumors（RECIST）, 3 months
Progress free survival（PFS）, 1 year|Overall survival（OS）, 3 years
By enrolling patients with recurrent laryngeal cancer adapted to enrolled criteria, this study will document for the first time the safety and the short and long term efficacy of the combined therapy using cryosurgery and natural killer (NK) cells.

The safety will be evaluated by statistics of adverse reactions. The efficacy will be evaluated according to local relief degree, progress free survival (PFS) and overall survival (OS).